America in Transition Pages

Monday, May 23, 2016

New T2D Drugs Face Skeptical FDA Advisors

(MedPage Today) -- Agency already uncertain about benefits of IDegLira, iGlarLixi combos

from MedPage Today Washington Watch http://ift.tt/1NHW3fE
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)